Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01555177
Other study ID # 12-099
Secondary ID
Status Recruiting
Phase N/A
First received March 9, 2012
Last updated November 3, 2014
Start date April 2012
Est. completion date February 2015

Study information

Verified date November 2014
Source Hamilton Health Sciences Corporation
Contact Victar Hsieh, MBBS PhD
Phone 1-905-527-4322
Email victarhsieh@yahoo.com
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

Background

It is commonly believed that a heart attack is caused by rupture of a plaque in the wall of the coronary artery, resulting in blood clots which impede blood flow. Currently, the investigators do not know whether heart attacks in patients who had a recent surgery are caused by the same disease process as those who did not have any surgery. This study will inform the investigators of very vital information about the cause of surgery-related heart attacks by taking images of coronary arteries using Optical Coherence Tomography (OCT). Images will also be taken from heart attack patients who did not have recent surgery, and the two groups will be compared.

OCT imaging

OCT is a relatively new imaging technology which is much better at taking images of the inside of the artery. OCT imaging procedure is carried out at the time of scheduled coronary angiogram, where a catheter with a mini-camera at its tip is advanced into the coronary artery, it will record video images of a length of the artery. These images will take approximately 3-4 seconds to obtain. Besides the OCT imaging being performed, the rest of the angiogram procedure is carried out in exactly the same way as it would normally proceed.

The OCT study will provide doctors with new information about the cause of surgery-related heart attacks, and will guide doctors in treating and preventing heart attacks in patients who undergo surgery.

Hypothesis

The investigators hypothesize that features of acute plaque rupture will be more common in patients with non-surgery related heart attacks compared to those which occur following surgery.

Design

Two groups of patients will be recruited(>20 in each group):

1. non-surgery related heart attack patients

2. patients who suffered from a heart attack following an operation.

Outcome measures

Using OCT, plaque features in coronary arteries of patients with heart attacks from both the surgical and non-surgical groups at the time of coronary angiogram will be compared.


Description:

The majority of spontaneous non-ST segment elevation myocardial infarctions (NSTEMI) are attributed to rupture of an unstable atherosclerotic plaque in an epicardial coronary artery with thrombus formation. On the other hand, the pathophysiology underlying myocardial infarction following non-cardiac surgery is not well understood. The literature suggests that a significant proportion of myocardial infarctions following surgery may result from decreased myocardial perfusion in the presence of stable coronary artery disease without plaque rupture or thrombus formation.

Intra-coronary Optical Coherence Tomography (OCT) provides superior visualisation of the vascular lumen and structures close to the arterial lumen compared to IVUS, including features of plaque instability, including atherosclerotic plaque contents, fibrous cap thickness, thin cap fibroatheromas (TCFA), macrophage infiltration and calcium (2-10). OCT is therefore an ideal imaging technique to examine the pathophysiology involved in POMI, where features of plaque rupture and thrombus formation can be clearly distinguished from stable plaques.

An improved understanding of the pathophysiology of MI following non-cardiac surgery will guide management more appropriately.

Primary objective

1. To identify features of acute plaque rupture in peri-operative myocardial infarction (POMI)

2. To compare frequency of acute plaque rupture imaging findings between POMI and non-operative non-ST-elevation myocardial infarction (NSTEMI)

Hypothesis

The investigators hypothesize that features of acute plaque rupture will be more common in patients with non-operative NSTEMI compared to POMI.

Outcome measures

1. OCT features of coronary plaque rupture will be obtained at the time of coronary angiography, these features include thin cap fibroatheroma, intramural thrombus and plaque fissuring. OCT data from NSTEMI and POMI patient groups will be compared. Data on other plaque features, including fibrous cap thickness, lipid core, minimum luminal cross-sectional area (CSA), ruptured cavity CSA will also be collected, and compared between the two patient groups.

There will be no clinical follow-up in this study.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age over 18

- Referred to coronary angiography with the view of revascularisation

Exclusion Criteria:

- ST elevation myocardial infarction

- Shock defined as the systolic blood pressure <90mmHg and tachycardia with heart rate >100 with evidence of systemic organ hypoperfusion.

- Inability to give consent

- Previous coronary artery bypass surgery due to the limited anticipated feasibility of OCT imaging in native vessels of patients with prior bypass grafts.

- PCI with stenting in the previous 6 months due to the elevated risk of stent related complications (thrombosis or restenosis) as the potential cause of the NSTEMI.

- GFR <35 due to need for additional 40-60 cc contrast during OCT imaging.

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Hamilton General Hospital Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
Victar Hsieh

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evidence of plaque rupture by OCT imaging OCT evidence of plaque rupture, presence of white or red thrombus will be collected at the time of coronary angiography. Day 1 No
Secondary Other features OCT features of atherosclerotic plaques. lFeatures of stable plaques in the coronary artery, including: Lipid core, fibrous cap, thin cap fibroatheroma, thick cap fibroatheroma, minimum luminal cross-sectional area, ruptured cavity CSA. Day 1 No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03278509 - Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART) Phase 4
Active, not recruiting NCT03646357 - BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function Phase 4
Recruiting NCT05230446 - PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions N/A
Completed NCT02983123 - One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
Recruiting NCT03541109 - A Polypill for Secondary Prevention of Ischemic Heart Disease Phase 3
Completed NCT03395041 - Periodontal Disease, Inflammation and Acute Coronary Syndromes
Recruiting NCT03863327 - EKG Criteria and Identification of Acute Coronary Occlusion
Completed NCT03389503 - Comparison of Left and Right Transradial Approach for CAG and PCI N/A
Completed NCT03208153 - the Invasive and Conservative Strategies in Elderly Frail Patients With Non-STEMI N/A
Completed NCT03690713 - International Collaboration of Comprehensive Physiologic Assessment
Completed NCT04161378 - Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB Trial
Recruiting NCT06040528 - Early Discharge Pathway Registry
Completed NCT03114995 - Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients Phase 4
Recruiting NCT02900001 - Routinely Deferred Versus Early Intervention in Elderly Patients With Non-ST-elevation Myocardial Infarction N/A
Completed NCT01491074 - Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction Phase 2
Not yet recruiting NCT05587621 - Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target) N/A
Completed NCT03391908 - Multiomics and Imaging-based Assessment of Vulnerable Coronary Plaques in Acute Coronary Syndromes